TY  - JOUR
PY  - 2018//
TI  - Study of fall risk-increasing drugs in elderly patients before and after a bone fracture
JO  - Postgraduate medical journal
A1  - Beunza-Sola, Mónica
A1  - Hidalgo-Ovejero, Ángel M.
A1  - Martí-Ayerdi, Jon
A1  - Sánchez-Hernández, José Germán
A1  - Menéndez-García, Miguel
A1  - García-Mata, Serafín
SP  - 76
EP  - 80
VL  - 94
IS  - 1108
N2  - BACKGROUND: Accidental falls have a significant economic and human impact. The use of certain drugs is one of the modifiable risk factors associated with these events. <br><br>OBJECTIVE: The aim of this study was to determine the prevalence of use and to explore changes in treatment with fall-related drugs in patients over 65 years of age admitted as a result of a fall-related fracture. <br><br>METHODS: Observational and prospective study performed in a tertiary level hospital. A list of fall risk-increasing drugs (FRIDs) was drawn up. The main study variables were number and type of FRIDs prescribed at admission and 1 month after the fracture and number, type, treating physician and place where changes in FRIDs were implemented. <br><br>RESULTS: In total, 252 patients were included. At admission, 91.3% were receiving at least one FRID, mean daily use was 3.1 FRIDs and the most frequently prescribed FRIDs were diuretics (18%), renin-angiotensin system-acting agents (15.8%) and antidepressants (15%). One month later, mean daily use was 3.4 FRIDs (p=0.099) and a significant increase was detected in the use of hypnotics (p=0.003) and antidepressants (p=0.042). A total of 327 changes in treatment were recorded (1.3 changes/patient). Of the changes, 52.6% were new prescriptions, 72.2% occurred at discharge and 56.6% were ordered by a geriatrician. <br><br>CONCLUSIONS: The use of FRIDs among patients with a fall-related fracture is very high. This use rises 1 month after the fracture, significantly in the case of hypnotics and antidepressants.<br><br>© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.<p />  <p>Language: en</p>
LA  - en
SN  - 0032-5473
UR  - http://dx.doi.org/10.1136/postgradmedj-2017-135129
ID  - ref1
ER  -